Physician profile
Michelle Chen
NPI 1568086197
$929.77
in general payments reported to CMS, 2019-2025
11 companies · $540 in 2025
The $540 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $146 · 2023: $204 · 2024: $40.09 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $277.97 | 2025 | |
| Motiva USA, LLC | $195.03 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $145.70 | 2022 | |
| Revance Therapeutics, INC. | $67.13 | 2025 | Daxxify |
| Tactile Systems Technology INC | $61.41 | 2023 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $52.31 | 2023 | Welireg |
| Aesculap, INC. | $40.09 | 2024 | Progav 2.0 |
| Insightec,INC | $28.36 | 2023 | Exablate |
| Janssen Biotech, INC. | $22.68 | 2023 | Imbruvica |
| Lilly USA, LLC | $21.66 | 2023 | Verzenio |
| Novartis Pharmaceuticals Corporation | $17.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.